GZMB and neoplasm: Consistently, immunohistochemistry staining confirmed that mRIP3R479K overexpression increased tumor Gr1+ MDSC, while inhibited CD8+ T cells and Granzyme B+ cytotoxic cells (Figs. 4I and S4C–E).